Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia
Sponsor: MeiraGTx, LLC
Summary
This study will assess the long-term safety and efficacy of bilateral intra-parotid administration of AAV2-hAQP1 in adults with Grade 2 or Grade 3 radiation-induced late xerostomia.
Official title: Long-term Follow-up of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
276
Start Date
2024-08-02
Completion Date
2032-02
Last Updated
2025-10-16
Healthy Volunteers
No
Interventions
AAV2-hAQP1
Administration of a prespecified concentration of AAV2-hAQP1 via Stensen's duct to each parotid gland
Locations (8)
Banner MD Anderson Cancer Center
Gilbert, Arizona, United States
Miami Cancer Institute at Baptist Health South Florida
Miami, Florida, United States
University of Iowa
Iowa City, Iowa, United States
University of Missouri
Columbia, Missouri, United States
Erie County Medical Center
Buffalo, New York, United States
Atrium Health
Charlotte, North Carolina, United States
Alleghany General Hospital
Pittsburgh, Pennsylvania, United States
Shirley and Jim Fielding Northeast Cancer Centre - Health Sciences North
Greater Sudbury, Ontario, Canada